1. Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents. (27th July 2022) Authors: Daneshvar, Elham; Tavakolpour, Soheil; Mahmoudi, Hamidreza; Daneshpazhooh, Maryam; Teimourpour, Amir; Aslani, Saeed; Balighi, Kamran Journal: International journal of dermatology Issue: Volume 62:Number 4(2023) Page Start: 567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Medication adherence and its possible associated factors in patients with acne vulgaris: A cross‐sectional study of 200 patients in Iran. Issue 6 (20th October 2020) Authors: Salamzadeh, Jamshid; Torabi Kachousangi, Samaneh; Hamzelou, Shahin; Naderi, Sina; Daneshvar, Elham Journal: Dermatologic therapy Issue: Volume 33:Issue 6(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗